AI Verdict
LGNZZ has stronger fundamentals based on our AI analysis.
LGNZZ vs LGIH Fundamental Comparison
| Metric | LGNZZ | LGIH |
|---|---|---|
| Revenue | $268.1M | $1.7B |
| Net Income | $124.5M | $72.6M |
| Net Margin | 46.4% | 4.3% |
| ROE | 12.2% | 3.5% |
| ROA | 8.0% | 1.8% |
| Current Ratio | 22.23x | N/A |
| Debt/Equity | 0.03x | 0.79x |
| EPS | $6.13 | $3.12 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LGNZZ vs LGIH: Frequently Asked Questions
Is LGNZZ or LGIH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LGNZZ has stronger fundamentals. LGNZZ is rated BUY (75% confidence) while LGIH is rated STRONG SELL (87% confidence). This is not investment advice.
How does LGNZZ compare to LGIH fundamentally?
LIGAND PHARMACEUTICALS INC has ROE of 12.2% vs LGI Homes, Inc.'s 3.5%. Net margins are 46.4% vs 4.3% respectively.
Which stock pays higher dividends, LGNZZ or LGIH?
LGNZZ has a dividend yield of N/A or no dividend while LGIH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LGNZZ or LGIH for long term?
For long-term investing, consider that LGNZZ has BUY rating with 75% confidence, while LGIH has STRONG SELL rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LGNZZ vs LGIH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LGNZZ vs LGIH, the AI consensus favors LGNZZ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.